6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.6-O-endosulfatases (SULFs) are key regulators of cancer metastasis. Targeting these enzymes offers novel strategies for combination cancer therapy against metastatic tumors.
Area Of Science
- Biochemistry
- Molecular Biology
- Oncology
Background
- Metastasis drives cancer mortality, necessitating deeper understanding of its mechanisms.
- 6-O-endosulfatases (SULF1 and SULF2) modify heparan sulfate proteoglycans (HSPGs), influencing cellular signaling pathways.
- SULF1 and SULF2 expression is observed in various cancers, implicating them in tumor progression.
Purpose Of The Study
- To review the involvement of SULFs in distinct steps of tumor metastasis.
- To elucidate the specific roles and molecular mechanisms of SULFs in the metastatic cascade.
- To discuss the therapeutic potential of targeting SULFs in combination cancer treatments.
Main Methods
- Literature review of studies investigating SULF1 and SULF2.
- Analysis of SULF involvement in cancer progression and metastasis.
- Examination of SULF roles across different cancer types.
Main Results
- SULFs participate in multiple stages of the metastasis process.
- Specific mechanisms by which SULFs promote tumor spread were elucidated.
- The impact of SULFs varies depending on the cancer type.
Conclusions
- SULFs are critical regulators of cancer metastasis.
- Targeting SULFs presents a promising strategy for combination therapy in metastatic cancers.
- Further research into SULFs could yield novel therapeutic approaches.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...